Skip to content
MedsAcross

Medicine

Elevidys kit

Delandistrogene moxeparvovec · Intravenous · Sarepta Therapeutics
Available on requestPrescription onlyUS FDA Cold chain

Elevidys kit is a prescription medicine containing Delandistrogene moxeparvovec for intravenous use, marketed by Sarepta Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

ELEVIDYS can be refrigerated for up to 14 days when stored at 2°C to 8°C (36º…

Key facts

Active ingredient (INN)
Delandistrogene moxeparvovec
Brand
Elevidys
Dosage form
Kit
Route
Intravenous
Packs
1 kit and 58 more
Marketing authorisation holder
Sarepta Therapeutics
Manufacturer
Sarepta Therapeutics
Origin register
US FDA, United States
Storage
ELEVIDYS can be refrigerated for up to 14 days when stored at 2°C to 8°C (36º F to 46º F) in the upright position. Do not place back in the refrigerator once brought to room temperature. ELEVIDYS is shipped and delivered at ≤ −60ºC [−76ºF]. Do not shake.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
M09AX15 Delandistrogene moxeparvovec
HS code (indicative)
3002.15Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
22 June 2023
Identifiers
RxCUI 797544, 2641679, 2641685 +7DailyMed set ID 3525abcd-fbd2-46c5-9706-cffdf2e8a361NDC 60923-520, 60923-548, 60923-558 +37Application BLA125781

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 kit in 1 carton * 10 mL in 1 vial, single-use * 10 pouch in 1 box / 1 swab in 1 pouch60923-501-10Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 11 pouch in 1 box / 1 swab in 1 pouch60923-502-11Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 12 pouch in 1 box / 1 swab in 1 pouch60923-503-12Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 13 pouch in 1 box / 1 swab in 1 pouch * 10 mL in 1 vial, single-use60923-504-13Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 14 pouch in 1 box / 1 swab in 1 pouch60923-505-14Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 15 pouch in 1 box / 1 swab in 1 pouch60923-506-15Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 16 pouch in 1 box / 1 swab in 1 pouch60923-507-16Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 17 pouch in 1 box / 1 swab in 1 pouch60923-508-17Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 18 pouch in 1 box / 1 swab in 1 pouch60923-509-18Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 19 pouch in 1 box / 1 swab in 1 pouch60923-510-19Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 20 pouch in 1 box / 1 swab in 1 pouch60923-511-20Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 21 pouch in 1 box / 1 swab in 1 pouch60923-512-21Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 22 pouch in 1 box / 1 swab in 1 pouch60923-513-22Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 23 pouch in 1 box / 1 swab in 1 pouch60923-514-23Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 24 pouch in 1 box / 1 swab in 1 pouch60923-515-24Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 25 pouch in 1 box / 1 swab in 1 pouch60923-516-25Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 26 pouch in 1 box / 1 swab in 1 pouch60923-517-26Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 27 pouch in 1 box / 1 swab in 1 pouch60923-518-27Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 28 pouch in 1 box / 1 swab in 1 pouch60923-519-28Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 29 pouch in 1 box / 1 swab in 1 pouch60923-520-29Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 30 pouch in 1 box / 1 swab in 1 pouch60923-521-30Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 31 pouch in 1 box / 1 swab in 1 pouch60923-522-31Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 32 pouch in 1 box / 1 swab in 1 pouch60923-523-32Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 33 pouch in 1 box / 1 swab in 1 pouch60923-524-33Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 34 pouch in 1 box / 1 swab in 1 pouch60923-525-34Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 35 pouch in 1 box / 1 swab in 1 pouch60923-526-35Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 36 pouch in 1 box / 1 swab in 1 pouch60923-527-36Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 37 pouch in 1 box / 1 swab in 1 pouch60923-528-37Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 38 pouch in 1 box / 1 swab in 1 pouch60923-529-38Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 39 pouch in 1 box / 1 swab in 1 pouch60923-530-39Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 40 pouch in 1 box / 1 swab in 1 pouch60923-531-40Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 41 pouch in 1 box / 1 swab in 1 pouch60923-532-41Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 42 pouch in 1 box / 1 swab in 1 pouch60923-533-42Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 43 pouch in 1 box / 1 swab in 1 pouch60923-534-43Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 44 pouch in 1 box / 1 swab in 1 pouch60923-535-44Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 45 pouch in 1 box / 1 swab in 1 pouch60923-536-45Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 46 pouch in 1 box / 1 swab in 1 pouch60923-537-46Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 47 pouch in 1 box / 1 swab in 1 pouch60923-538-47Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 48 pouch in 1 box / 1 swab in 1 pouch60923-539-48Sarepta Therapeutics22 June 2023
1 kit in 1 carton * 10 mL in 1 vial, single-use * 49 pouch in 1 box / 1 swab in 1 pouch60923-540-49Sarepta Therapeutics22 June 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Clinical summary

Delandistrogene moxeparvovec is a prescription medicine indicated for the treatment of patients 4 years of age and older with Duchenne muscular dystrophy (DMD), who are ambulatory and have a confirmed mutation in the DMD gene. MedsAcross supplies Delandistrogene moxeparvovec for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Delandistrogene moxeparvovec

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Elevidys kit for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.